We use cookies to give you the best possible experience on our website.

Access to the life science market can be a headache for multinational pharma and medical device companies, let alone small-medium sized enterprises (SMEs). SMEs can face significant challenges to introduce new and innovative products into the health and social care market.

The Innovation Nexus provides a single point of access for SMEs in the life science sector to a network of specialist support within Greater Manchester. 

The Innovation Nexus is a gateway to a holistic business growth support offering, focused on the specialist needs of life science SMEs, delivered through a coherent support strategy and an all-inclusive approach to helping businesses develop their growth strategies. 

The aim of the Innovation Nexus is to deliver long-term health and wealth benefits to Greater Manchester through investment, innovation, education and business growth, ultimately improving the health and wellbeing of the Greater Manchester population (and beyond). 

 

INDUSTRY PARTNERSHIP WILL BE A KEY COMPONENT OF HOW HEALTH SYSTEMS WILL IMPROVE HEALTH OUTCOMES FOR THE POPULATIONS THEY SERVE

The challenge for healthcare businesses

Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.

How can the Innovation Nexus help?

Help with navigating NHS procurement

Information about funding and investment

Help with setting up a trial of your innovation

Information on science parks and office locations in the GM AHSN footprint

Connections to organisations that can help you progress your innovation

Speak directly to a GM AHSN advisor with NHS expertise

Latest news Latest news

Back

Innovative British healthcare companies invited to take part in Texas ‘medtech’ mission

Pioneering UK healthcare companies keen to develop or strengthen partnerships in Texas are being urged to take part in the next medtech mission to the state.

Organised by the Association of British Healthcare Industries (ABHI’s), in partnership with leading Academic Health Science Networks (AHSNs) and supported by the UK Government, the mission aims to forge relationships between UK companies and Texas healthcare establishments.

Taking place from 4 to10 March 2017, the unique visit offers companies to opportunity to connect with a variety of healthcare systems, R&D, buying and professional organisations at the highest levels.

The mission also aims to provide companies with unprecedented access to key opinion leaders (KOLs) and leadership teams in world-class hospital systems and medical centres across the state.

The mission is timed to coincide with the healthcare track of South by Southwest (SXSW) in Austin, thus providing a further opportunity to meet with leaders in health and technology.

ABHI International Director, Paul Benton, said:

“The ABHI mission is part of a rolling series of ABHI led visits to Texas. It builds on the highly successful visits in 2016, which saw companies benefit from introductions and engagement with hospital and clinical leaders including the US military as well as GPO’s, distributors and professional business support organisations.

“We are currently recruiting for the mission and are keen to talk to anyone who is looking to strengthen export links with the state.”

James Whitticase, CEO, OBS Medical who attended the previous med tech mission, said:

“Attending the mission in October was a real eye opener, the connections and network the ABHI has built in Texas is nothing short of astounding and surpassed all our expectations. The quality, seniority and willingness to engage from those we met was incredible, we will certainly be going back to Texas with ABHI.”

Texas has been chosen for the mission as it is an economic powerhouse.

  • It has the second largest GDP of any US State at 1.7 trillion dollars and were it a sovereign country, it would be ranked as the 12th largest economy in the world by GDP.
  • It has the highest proportion of hospitals of any state in the US and is ranked 3rd in the US on overall healthcare expenditure, beating the City of London or even countries such as Portugal. 
  • Texas is the 7th largest health economy in the world and has significant ambition to be a global healthcare and lifesciences player over the next decade.

If you would like to find out more about the ABHI mission to Texas contact Scarlett O’Sullivan, International Executive on +44 (0)20 7960 4368 or e-mail:scarlett.osullivan@abhi.org.uk


Bespoke industry support from NHS experts

If you are a business with an innovative product or service that you believe has the potential to benefit the healthcare market, the Innovation Nexus is your gateway to access a network of specialist advice and support.

Information and guidance

Access information and guidance on a range of topics related to working with and selling to the NHS, and find clear signposts to organisations that can help you achieve your goals.

Are you an innovator in the NHS or academia?

Read more here >>

Subscribe to our mailing list

* indicates required